Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-27,400
Closed -$1.85M 4222
2025
Q3
$1.85M Buy
+27,400
New +$1.82M ﹤0.01% 2286
2025
Q2
Sell
-12,000
Closed -$741K 3419
2025
Q1
$741K Buy
+12,000
New +$795K ﹤0.01% 2450
2024
Q4
Sell
-28,900
Closed -$2.35M 3232
2024
Q3
$2.35M Buy
+28,900
New +$2.31M ﹤0.01% 1569
2023
Q4
Sell
-10,000
Closed -$694K 1869
2023
Q3
$694K Sell
10,000
-1,200
-11% -$90.7K ﹤0.01% 1344
2023
Q2
$907K Buy
+11,200
New +$915K ﹤0.01% 1080
2019
Q1
Sell
-11,800
Closed -$485K 752
2018
Q4
$485K Buy
+11,800
New +$484K ﹤0.01% 627

Other funds holding HOLX

IMC Chicago's HOLX Position: Q4 2023 in Review

IMC Chicago sold out of Hologic (HOLX) in Q4 2023, closing a stake of 10,581 shares — an estimated $737K sold.

IMC Chicago first reported a position in HOLX in Q3 2023 and held it in 1 quarter. The position peaked at $734K in Q3 2023. 732 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • IMC Chicago reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • IMC Chicago sold 10,581 Hologic shares in Q4 2023, an estimated $737K.
  • IMC Chicago first reported a position in Hologic in Q3 2023 and held it in 1 quarter.
  • IMC Chicago's Hologic position peaked at $734K in Q3 2023.
  • 732 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on IMC Chicago's 13F filing for Q4 2023, filed 9 Feb 2024.